Wildeman A G, Sassone-Corsi P, Grundström T, Zenke M, Chambon P
EMBO J. 1984 Dec 20;3(13):3129-33. doi: 10.1002/j.1460-2075.1984.tb02269.x.
A nuclear extract prepared from HeLa cells has been used to study in vitro the transcription of the SV40 early promoter. The deletion of the enhancer results in a strong decrease of transcription, with spermidine and MgCl2 being critical variables in the transcription reactions. Furthermore a competition assay indicates that the stimulation by the enhancer is due to a specific trans-acting factor(s) which acts on it. This factor appears not to interact with SV40 or adenovirus-2 major late upstream (distal) promoter sequences, and its ability to bind to the enhancer is diminished by mutations known to decrease enhancer function in vivo and in vitro.
从HeLa细胞制备的核提取物已用于体外研究SV40早期启动子的转录。增强子的缺失导致转录显著下降,亚精胺和MgCl2是转录反应中的关键变量。此外,竞争试验表明,增强子的刺激作用是由于作用于其上的一种或多种特异性反式作用因子。该因子似乎不与SV40或腺病毒2型主要晚期上游(远端)启动子序列相互作用,并且其与增强子结合的能力会因已知在体内和体外会降低增强子功能的突变而减弱。